Call toll-free 800.328.1267
Chipmakers have led the market all year, but they could be losing their edge as investors position for new conditions into yearend. The Philadelphia Semiconductor Index ($SOX) dominated price action in the first half and remained the top performer through the end of...
Stocks are nearing record highs as earning season begins. The S&P 500 rose 1.8 percent between Friday, January 5, and Friday, January 12. The index managed to hold a support level from mid-December and had its highest weekly close ever. The Dow Jones Industrial...
Stocks kept fighting higher last month as inflation slowed and earnings beat estimates. The S&P 500 rose 1.5 percent in April, its third gain in the first four months of the year. The index has returned to challenge its February high, and is still above falling...
Stocks have stopped moving as investors wait for more news on corporate earnings and interest rates. The S&P 500 slid 0.1 percent between Friday, April 14, and Friday, April 21. If that percentage change sounds small, consider that the index fluctuated less than...
Stocks are trying to bounce as investors await key earnings and hope for slower rate hikes. The S&P 500 rose 4.7 percent between Friday, October 14, and Friday, October 21. It was the biggest weekly gain since June, with every major sector advancing. More than...
Health-care stocks have lagged the market for years, but now the sector is coming to life as the coronavirus pandemic winds down. The SPDR Health Care ETF (XLV) has outperformed the S&P 500 by 2.5 percentage points so far this week. That puts it on pace for its...
This week's earnings featured a huge quarter from electric-car maker Tesla and several positive surprises in the housing space. TSLA's earnings and revenue beat estimates in the second quarter, despite coronavirus shuttering some factories. Its manufacturing practices...
Market Insights has covered the split between the new winners and losers in technology. Something similar seems to be underway in the health-care sector. Drug makers whose products offer the promise of growth have led. These includes biotechnology stocks, which keep...
A handful of big companies announced strong results in the last week, but wider problems are tarnishing the story. Feeble semiconductor demand, doubts about the industrial sector and lackluster guidance emerged as recurring themes as we progress through the busiest...